Viridian Therapeutics, Inc.\DE

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC VRDN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

139,360

Value ($000)

4,337

Weight

0.0%

2022 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,337	0.0%	139,360	12/31/2025
2025 Q3	11/14/2025	2,999	0.0%	138,980	9/30/2025
2025 Q2	8/14/2025	2,658	0.0%	190,104	6/30/2025
2025 Q1	5/19/2025	1,760	0.0%	130,570	3/31/2025
2024 Q4	2/14/2025	2,220	0.0%	115,782	12/31/2024
2024 Q3	11/14/2024	2,036	0.0%	89,496	9/30/2024
2024 Q2	8/14/2024	902	0.0%	69,330	6/30/2024
2024 Q1	5/15/2024	496	0.0%	28,309	3/31/2024
2023 Q4	2/14/2024	330	0.0%	15,161	12/31/2023
2023 Q3	11/13/2023	233	0.0%	15,161	9/30/2023
2023 Q2	8/11/2023	601	0.0%	23,621	6/30/2023
2023 Q1	5/15/2023	601	0.0%	23,621	3/31/2023
2022 Q4	2/14/2023	569	0.0%	19,470	12/31/2022